Our clients’ presentations at EASL ~The Digital International Liver Congress™ 2020 ~

Our clients presented data on treatment of NASH using STAMTM model at the EASL ~The Digital International Liver CongressTM 2020~ (August 27-29).


For detailed information, see the below URL.



Poster #FRI105

Therapeutic efficacy of the chitotriosidase inhibitors in STAM model of non-alcoholic steatohepatitis

Institution: OncoArendi Therapeutics SA (Paland)


Poster #FRI119

Novel autophagy inducer, a4368 improves non-alcoholic steatohepatitis in mice

Institution: Autophagy Sciences (Korea)


Poster #FRI495

2-deoxy-D-glucose encapsulated PLGA nanoparticles suppress hepatocellular carcinoma through cytotoxic effect and activation of antitumor immunity

Institution: Kawasaki Medical School (Japan)


Poster #SAT058

GPNMB modulates hepatic steatogenesis and liver cancer

Institution: Heidelberg University (Germany)